The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hypertension, Portal

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hypertension, Portal


Psychiatry related information on Hypertension, Portal


High impact information on Hypertension, Portal


Chemical compound and disease context of Hypertension, Portal


Biological context of Hypertension, Portal


Anatomical context of Hypertension, Portal


Gene context of Hypertension, Portal


Analytical, diagnostic and therapeutic context of Hypertension, Portal


  1. A randomized clinical trial of propranolol for the prevention of initial bleeding in cirrhosis with portal hypertension. Pagliaro, L., Pasta, L., D'Amico, G., Filippazzo, M.G., Tinè, F., Morabito, A., Ferrari, A., Marenco, G., De Pretis, G. N. Engl. J. Med. (1986) [Pubmed]
  2. Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Starzl, T.E., Porter, K.A., Francavilla, A., Iwatsuki, S. Lancet (1983) [Pubmed]
  3. Propranolol--a medical treatment for portal hypertension? Lebrec, D., Nouel, O., Corbic, M., Benhamou, J.P. Lancet (1980) [Pubmed]
  4. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Arakawa, T., Satoh, H., Fukuda, T., Nakamura, H., Kobayashi, K. Gastroenterology (1987) [Pubmed]
  5. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis. Fernández, M., García-Pagán, J.C., Casadevall, M., Mourelle, M.I., Piqué, J.M., Bosch, J., Rodés, J. Gastroenterology (1996) [Pubmed]
  6. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Fargion, S., Mandelli, C., Piperno, A., Cesana, B., Fracanzani, A.L., Fraquelli, M., Bianchi, P.A., Fiorelli, G., Conte, D. Hepatology (1992) [Pubmed]
  7. Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine. Prkacin, I., Separovic, J., Aralicia, G., Perovic, D., Gjurasin, M., Lovric-Bencic, M., Stancic-Rokotov, D., Staresinic, M., Anic, T., Mikus, D., Sikiric, P., Seiwerth, S., Mise, S., Rotkvic, I., Jagic, V., Rucman, R., Petek, M., Turkovic, B., Marovic, A., Sebecic, B., Boban-Blagaic, A., Kokic, N. J. Physiol. Paris (2001) [Pubmed]
  8. Source of raised serum estrogens in male rats with portal bypass. Farrell, G.C., Koltai, A., Murray, M. J. Clin. Invest. (1988) [Pubmed]
  9. GRK2 makes trouble: a no-NO in portal hypertension. Semela, D., Langer, D.A., Shah, V. Gastroenterology (2006) [Pubmed]
  10. Angiotensin receptor antagonists in portal hypertension: fog over paradise. Speer, C.A., Ferrentino, N. Gastroenterology (2002) [Pubmed]
  11. 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. Graupera, M., García-Pagán, J.C., Titos, E., Claria, J., Massaguer, A., Bosch, J., Rodés, J. Gastroenterology (2002) [Pubmed]
  12. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Escorsell , A., Bandi, J.C., Andreu, V., Moitinho, E., García-Pagán, J.C., Bosch, J., Rodés, J. Gastroenterology (2001) [Pubmed]
  13. Hyposensitivity to vasopressin in a hemorrhaged-transfused rat model of portal hypertension. Kravetz, D., Cummings, S.A., Groszmann, R.J. Gastroenterology (1987) [Pubmed]
  14. Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. Guarner, C., Soriano, G., Such, J., Teixidó, M., Ramis, I., Bulbena, O., Roselló, J., Guarner, F., Gelpi, E., Balanzó, J. Gastroenterology (1992) [Pubmed]
  15. Nitroglycerin in the treatment of portal hypertension. Sweeting, J. Gastroenterology (1991) [Pubmed]
  16. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Tanoue, K., Ohta, M., Tarnawski, A.S., Wahlstrom, K.J., Sugimachi, K., Sarfeh, I.J. Gastroenterology (1996) [Pubmed]
  17. Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions. Blei, A.T., Garcia-Tsao, G., Groszmann, R.J., Kahrilas, P., Ganger, D., Morse, S., Fung, H.L. Gastroenterology (1987) [Pubmed]
  18. Insulin resistance in noncirrhotic idiopathic portal hypertension. Petrides, A.S., Riely, C.A., DeFronzo, R.A. Gastroenterology (1991) [Pubmed]
  19. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Kravetz, D., Bosch, J., Arderiu, M., Pilar Pizcueta, M., Rodés, J. Hepatology (1989) [Pubmed]
  20. Noninvasive monitoring of patients with chronic hepatitis C. Fontana, R.J., Lok, A.S. Hepatology (2002) [Pubmed]
  21. Portal hypertension in vinyl chloride monomer workers. A hemodynamic study. Blendis, L.M., Smith, P.M., Lawrie, B.W., Stephens, M.R., Evans, W.D. Gastroenterology (1978) [Pubmed]
  22. Portal hypertension and gastric mucosal injury in rats. Effects of alcohol. Sarfeh, I.J., Tarnawski, A., Malki, A., Mason, G.R., Mach, T., Ivey, K.J. Gastroenterology (1983) [Pubmed]
  23. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Pinzani, M., Milani, S., De Franco, R., Grappone, C., Caligiuri, A., Gentilini, A., Tosti-Guerra, C., Maggi, M., Failli, P., Ruocco, C., Gentilini, P. Gastroenterology (1996) [Pubmed]
  24. Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases. Makino, N., Suematsu, M., Sugiura, Y., Morikawa, H., Shiomi, S., Goda, N., Sano, T., Nimura, Y., Sugimachi, K., Ishimura, Y. Hepatology (2001) [Pubmed]
  25. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Krowka, M.J., Frantz, R.P., McGoon, M.D., Severson, C., Plevak, D.J., Wiesner, R.H. Hepatology (1999) [Pubmed]
  26. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. Angermayr, B., Mejias, M., Gracia-Sancho, J., Garcia-Pagan, J.C., Bosch, J., Fernandez, M. J. Hepatol. (2006) [Pubmed]
  27. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Reynaert, H., Geerts, A. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  28. Pulmonary expression of iNOS and HO-1 protein is upregulated in a rat model of prehepatic portal hypertension. Schroeder, R.A., Ewing, C.A., Sitzmann, J.V., Kuo, P.C. Dig. Dis. Sci. (2000) [Pubmed]
  29. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Stumm, M.M., D'Orazio, D., Sumanovski, L.T., Martin, P.Y., Reichen, J., Sieber, C.C. Liver (2002) [Pubmed]
  30. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Pizcueta, M.P., García-Pagán, J.C., Fernández, M., Casamitjana, R., Bosch, J., Rodés, J. Gastroenterology (1991) [Pubmed]
  31. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients. Millette, B., Huet, P.M., Lavoie, P., Viallet, A. Gastroenterology (1975) [Pubmed]
  32. Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Huet, P.M., Guillaume, E., Cote, J., Légaré, A., Lavoie, P., Viallet, A. Gastroenterology (1975) [Pubmed]
  33. A comparison of acute reversible pre- and postsinusoidal portal hypertension on salt and water retention in the dog. Campbell, V., Greig, P.D., Cranford, J., Langer, B., Silverman, M., Blendis, L.M. Hepatology (1982) [Pubmed]
  34. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis. Cejna, M., Peck-Radosavljevic, M., Thurnher, S.A., Hittmair, K., Schoder, M., Lammer, J. Radiology. (2001) [Pubmed]
WikiGenes - Universities